Correlation Between AN2 Therapeutics and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Cyteir Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Cyteir Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Cyteir Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between AN2 and Cyteir is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Cyteir Therapeutics
If you would invest 107.00 in AN2 Therapeutics on October 4, 2024 and sell it today you would earn a total of 31.00 from holding AN2 Therapeutics or generate 28.97% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.61% |
Values | Daily Returns |
AN2 Therapeutics vs. Cyteir Therapeutics
Performance |
Timeline |
AN2 Therapeutics |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AN2 Therapeutics and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AN2 Therapeutics and Cyteir Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.AN2 Therapeutics vs. Nurix Therapeutics | AN2 Therapeutics vs. Seer Inc | AN2 Therapeutics vs. HCW Biologics | AN2 Therapeutics vs. MediciNova |
Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |